This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It’s administered with a tiny needle that punctures ...

Scripps case series suggests some patients can maintain GLP-1 weight loss by spacing semaglutide or tirzepatide doses.

In this guide, learn the eligibility criteria for brand-name semaglutide, cost and insurance coverage, safety risks of compounded semaglutide and how to find a reputable telehealth provider online.

Dr Reddy's Laboratories has launched its generic Semaglutide injection in Canada. This marks a significant step for the ...

Wegovy and Mounjaro have revolutionized obesity treatment and led to significant weight loss for many patients – but with it ...

In the ever-evolving landscape of weight management and diabetes treatment, semaglutide has emerged as a significant player. Originally approved by the FDA for managing type 2 diabetes under Ozempic, ...

Dr. Reddy’s launches generic Semaglutide Injection in Canada, marking the first G7 approval for this diabetes treatment.

Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties from compounding the drug. Our FDA/Food, Drug & Device and ...

Apotex Inc. ("Apotex" or the "Company"), the largest Canadian‑based global health company, today announced the commercial ...

Dr Reddy's Laboratories on Saturday said it has launched its generic version of Semaglutide injection used in treatment of ...